Superior patient care starts with Aerogen Ultra
Aerogen’s pioneering aerosol drug delivery technology is transforming emergency medicine in hospitals worldwide.
Compared to a standard small volume nebuliser (SVN);
Our unique palladium vibrating mesh technology, Aerogen Vibronic®, is a breakthrough in aerosol drug delivery and is at the heart of all our products.
The central aperture plate is just 5mm in diameter and is perforated with 1000 precision formed holes, that vibrate at 128,000 times per second, to produce the optimum particle size for deep lung penetration.
Call Us Today for Demo
Used with the Aerogen Solo the Aerogen Ultra offers superior drug delivery and improved patient response in emergency departments
Better is Aerogen
Aerogen in the ICU
Aerogen puts you in control ensuring confidence and consistency of patient care in your ICU
ICU
Aerogen in the ED
Compared to a standard jet nebulizer the Aerogen Ultra delivers significantly more medication in half the time¹ with improved patient response², also helping to reduce hospital admissions from the ED³.
ED
Aerogen on the Wards
Aerogen’s high performance aerosol drug delivery systems have been designed with maximum flexibility that allows medication delivery treatment to travel with patients throughout the hospital.
Wards
Aerogen in Pediatrics
The Aerogen Solo is virtually silent in operation and with no added flow is ideal for aerosol drug delivery to your pediatric patients.
Pediatrics
Ventilated Pediatrics
Non Ventilated Paediatrics
Aerogen and Covid-19
Aerogen – bringing a lower risk of transmission of patient generated infectious aerosol.
Aerogen Solo
Pioneering aerosol drug delivery nebulizer for single patient use
Aerogen Ultra
Superior aerosol drug delivery in the emergency department
The Aerogen Ultra is transforming the treatment of patients in emergency departments worldwide
Get Free Demo
Get Free Demo
Superior patient care starts with Aerogen Ultra
Aerogen’s pioneering aerosol drug delivery technology is transforming emergency medicine in hospitals worldwide.
Compared to a standard small volume nebuliser (SVN);
32%
reduction in
ED
admission rates1
37min
achieved symptom
control with
2.5mg salbutamol
85%
achieved symptom
control with
2.5mg salbutamol
“We saw a decrease in admissions, an increase in discharge and a decrease in length of stay.”1
Robert Dunne, MD
Vice Chair of Emergency Medicine
St. John Hospital & Medical Center, Detroit
Call Us
+91 22 6694 2784
+91 99 2007 0500
Reach Us
Email - info@criticam.com
Add - C-308, Morya House,
Andheri Link Road,
Andheri West,
Mumbai 400 053
Reach Us
Add - Sneha Shanti Bldg. 127/3B/2, Kamlesh Society, Karishma Chowk, Kothrud, Pune- 411029